OPIANT PHARMACEUTICALS, INC. - FORM 8-K/A - EX-16 - EXHIBIT 16 - October 22, 2009

Attached files

file filename
8-K/A - LIGHTLAKE THERAPEUTICS INC. 8-K/A - OPIANT PHARMACEUTICALS, INC.a6081059.txt
EX-16 2 a6081059ex16.txt EXHIBIT 16 Exhibit 16 October 22, 2009 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: Madrona Ventures Inc. Ladies and Gentlemen: We are the former independent accountants for Madrona Ventures Inc. (the "Company"). We have been furnished with a copy of the Company's response to Item 4.01 of Form 8-K/A disclosing our dismissal as independent public accountants of the Company. We confirm our agreement with the statements made in such disclosure insofar as they relate to our firm. We are not in a position to agree or disagree with the statements in such disclosure regarding the appointment of or consultations with new independent accountants by the Company. Yours truly, "DMCL" Dale Matheson Carr-Hilton LaBonte LLP Chartered Accountants Barry Hartley, CA

Stock widget

Investing forum

OPIANT PHARMACEUTICALS, INC. Reports